A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
The purpose of this study is to assess the BA of 30 or 60 milligram (mg) dexlansoprazole capsule manufactured at TOB (Takeda GmbH Plant Oranienburg) to the corresponding 30 or 60 mg dexlansoprazole manufactured at TPC (Takeda Pharmaceutical Company Ltd.).
提供机构：
ClinicalTrials.gov
